Rudoltz Marc 4
4 · Tango Therapeutics, Inc. · Filed Nov 3, 2021
Insider Transaction Report
Form 4
Rudoltz Marc
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-11-01+350,000→ 350,000 totalExercise: $12.91Exp: 2031-11-01→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable over a four-year period, at a rate of 25% on October 18, 2022, with the remaining option shares vesting in 36 equal monthly installments thereafter.